111In-pentetreotide scintigraphy: procedure guidelines for tumour imaging.
| Data(s) |
2010
|
|---|---|
| Resumo |
This document provides general information about somatostatin receptor scintigraphy with (111)In-pentetreotide. This guideline should not be regarded as the only approach to visualise tumours expressing somatostatin receptors or as exclusive of other nuclear medicine procedures useful to obtain comparable results. The aim of this guideline is to assist nuclear medicine physicians in recommending, performing, reporting and interpreting the results of (111)In-pentetreotide scintigraphy. |
| Identificador |
http://serval.unil.ch/?id=serval:BIB_236939345F57 isbn:1619-7089[electronic], 1619-7070[linking] pmid:20461371 doi:10.1007/s00259-010-1473-6 isiid:000278833100026 |
| Idioma(s) |
en |
| Fonte |
European Journal of Nuclear Medicine and Molecular Imaging, vol. 37, no. 7, pp. 1441-1448 |
| Palavras-Chave | #In-111-Pentetreotide Scintigraphy; Tumour Imaging; Procedure Guidelines; Neuroendocrine Tumours; Indications; Somatostatin Receptor Scintigraphy; Neuroendocrine Gastroenteropancreatic Tumors; Carcinoid-Tumors; Analog Scintigraphy; Endocrine Tumors; Management; Indium-111-Pentetreotide; Expression; Impact; Gastrinomas |
| Tipo |
info:eu-repo/semantics/review article |
